Finance

Lists
EMR:NYSE
Emerson Electric Co
$152.15
-0.44%
(-0.67) 1D
$152.55
+0.26% (+0.40)
After hours
Closed: Sep 8, 4:03:55 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EMR...
Open
$153.18
High
$153.95
Low
$151.70
Mkt. cap
84.87B
Avg. vol.
2.71M
Volume
1.93M
Dividend
1.46%
Quarterly dividend
$0.56
Ex-dividend date
Aug 14, 2026
P/E ratio
33.27
52-wk high
$166.35
52-wk low
$122.64
EPS
$4.57
Beta
1.24
Shares outstanding
557.80M
No. of employees
71K
Open
$153.18
High
$153.95
Low
$151.70
Mkt. cap
84.87B
Avg. vol.
2.71M
Volume
1.93M
Dividend
1.46%
Quarterly dividend
$0.56
Ex-dividend date
Aug 14, 2026
P/E ratio
33.27
52-wk high
$166.35
52-wk low
$122.64
EPS
$4.57
Beta
1.24
Shares outstanding
557.80M
No. of employees
71K
News stories
From web sources and news partners
Profile
Emerson Electric Co., commonly known as Emerson, is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company manufactures and delivers a range of industrial automation and control systems, climate control solutions, measurement and analytical instrumentation, and provides engineering services for industrial, commercial, and consumer markets. Wikipedia
About Emerson Electric Co
CEOLal Karsanbhai
Employees71K
FoundedSep 24, 1890
HeadquartersSt. Louis, Missouri, United States
Sectorcapital good
Websiteemerson.com
Analyst ratings
Based on 16 analysts giving stock ratings to EMR in the past 3 months
Buy
Buy
10
Hold
5
Sell
1
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for EMR in the last 3 months.
Highest
Current $152.15
$275.00 (+80.74%)
Average
$177.81 (+16.86%)
Lowest
$135.00 (-11.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Bernstein
Buy
Maintained
$186.00
+22.2%
09/03/2026
Christopher Snyder
Morgan Stanley
Sell
Maintained
$135.00
-11.3%
08/28/2026
Chris Dankert
D.A. Davidson
Hold
Reiterated
$155.00
+1.9%
08/24/2026
Andrew Obin
Bank of America Securities
Buy
Maintained
$191.00
+25.5%
08/13/2026
Unknown Analyst
Oppenheimer
Hold
Maintained
$275.00
+80.7%
08/07/2026
John Eade
Argus Research
Buy
Maintained
$175.00
+15%
08/06/2026
Jim Kelleher
Argus Research
Buy
Maintained
$175.00
+15%
08/06/2026
Chigusa Katoku
J.P. Morgan
Buy
Maintained
$169.00
+11.1%
08/06/2026
Daniel DiCicco
BMO Capital
Hold
Reiterated
$175.00
+15%
08/06/2026
Alexander Virgo
Evercore ISI
Buy
Maintained
$190.00
+24.9%
08/05/2026
Michael Halloran
Robert W. Baird
Hold
Maintained
$171.00
+12.4%
08/05/2026
Deane Dray
RBC Capital
Buy
Maintained
$179.00
+17.6%
08/04/2026
Unknown Analyst
UBS
Buy
Maintained
$180.00
+18.3%
08/05/2026
Andrew Kaplowitz
Citi
Buy
Maintained
$182.00
+19.6%
08/05/2026
Kenneth Newman
KeyBanc
Buy
Reiterated
$170.00
+11.7%
08/05/2026
Nigel Coe
Wolfe Research
Buy
Maintained
$167.00
+9.8%
07/09/2026
Varun Govindaraj
Bernstein
Buy
Maintained
$175.00
+15%
07/01/2026
Unknown Analyst
Davidson Capital
Hold
Initiated
$145.00
-4.7%
06/16/2026
Unknown Analyst
D.A. Davidson
Hold
Initiated
$145.00
-4.7%
06/15/2026
Joe O'Dea
Wells Fargo
Hold
Reiterated
$155.00
+1.9%
05/08/2026
Unknown Analyst
Argus Research
Buy
Maintained
$175.00
+15%
05/08/2026
Joseph C Giordano
TD Cowen
Hold
Reiterated
$150.00
-1.4%
05/07/2026
Julian Mitchell
Barclays
Hold
Maintained
$144.00
-5.4%
05/06/2026
Stephen Volkmann
Jefferies
Buy
Upgraded
$175.00
+15%
03/31/2026
Raj Ray
BMO Capital
Hold
Initiated
$150.00
-1.4%
03/27/2026
Tommy Moll
Stephens
Hold
Maintained
$155.00
+1.9%
02/09/2026
Nicole Deblase
Deutsche Bank
Hold
Downgraded
$170.00
+11.7%
02/04/2026
Brett Linzey
Mizuho Securities
Buy
Maintained
$173.00
+13.7%
02/04/2026
Last report
Aug 4, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$1.71 / $1.68
+1.96%beat
Revenue / Est. (USD)
4.87B / 4.80B
+1.46%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.86B
4.35B
4.56B
4.87B
Cost of goods sold
2.34B
2.04B
2.14B
2.22B
Cost of revenue
2.34B
2.04B
2.14B
2.22B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.33B
1.24B
1.32B
1.34B
Operating expense
710.00M
1.24B
1.32B
1.34B
Total operating expenses
3.05B
3.28B
3.46B
3.56B
Operating income
1.81B
1.07B
1.11B
1.31B
Other non operating income
-803.00M
-181.00M
-164.00M
-183.00M
EBT including unusual items
796.00M
775.00M
793.00M
916.00M
EBT excluding unusual items
895.00M
785.00M
839.00M
1.02B
Income tax expense
160.00M
169.00M
175.00M
198.00M
Effective tax rate
20.10%
21.81%
22.07%
21.62%
Other operating expenses
-620.00M
-
-
-
Net income
636.00M
605.00M
618.00M
718.00M
Net profit margin
13.10%
13.92%
13.55%
14.73%
Earnings per share
1.62
1.46
1.54
1.71
Interest and investment income
30.00M
26.00M
26.00M
25.00M
Interest expense
-122.00M
-116.00M
-110.00M
-110.00M
Net interest expenses
-92.00M
-90.00M
-84.00M
-85.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.16B
1.41B
1.45B
1.66B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps